NCT05002023 PRINCE Study - Cohort Study of Healthy Pregnant Women Followed by the Assessment of Children´s Health and Immunity
| NCT ID | NCT05002023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2011-02-02 |
| Primary Completion | 2050-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2011-02-02 with a primary completion date of 2050-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the PRINCE study we recruit healthy but also diseased pregnant women into a cohort study, followed by the assessment of children´s health and immunity at birth and during the first 10 years of life. This unique cohort allows for testing the impact of prenatal challenges on children´s health.
Eligibility Criteria
Inclusion Criteria: * Pregnant women * \>18 years of age * able to understand and sign the papers of consent * singleton pregnancy Exclusion Criteria: : * \<18 years of age * unable to give consent * multiple pregnancy * nicotine abuse * fetal aberration
Contact & Investigator
Prof. Dr. Anke Diemert, MD
PRINCIPAL INVESTIGATOR
Department of Obstetrics and Fetal Medicine, Medical Center Hamburg-Eppendorf (UKE)
Frequently Asked Questions
Who can join the NCT05002023 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05002023 currently recruiting?
Yes, NCT05002023 is actively recruiting participants. Contact the research team at a.diemert@uke.de for enrollment information.
Where is the NCT05002023 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT05002023 clinical trial?
NCT05002023 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The principal investigator is Prof. Dr. Anke Diemert, MD at Department of Obstetrics and Fetal Medicine, Medical Center Hamburg-Eppendorf (UKE). The trial plans to enroll 1,000 participants.